# Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)

> **NCT03035344** · — · UNKNOWN · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 25 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia, Pediatric
- Metabolism Disorder

## Interventions

- **OTHER:** Metabolome study

## Key facts

- **NCT ID:** NCT03035344
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2017-05
- **Final completion:** 2018-11
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2017-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03035344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03035344, "Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT03035344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
